Equities
Health CarePharmaceuticals and Biotechnology
  • Price (GBX)1,182.00
  • Today's Change-20.00 / -1.66%
  • Shares traded61.33k
  • 1 Year change-17.05%
  • Beta0.4791
Data delayed at least 20 minutes, as of Jul 04 2022 16:35 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

On Monday, Abcam PLC (ABC:LSE) closed at 1,182.00, 16.62% above the 52 week low of 1,013.57 set on May 10, 2022.
52-week range
Today
1,013.57May 10 20221,760.00Jan 11 2022
Markit short selling activity
Low
Med
High
Open1,203.00
High1,204.00
Low1,182.00
Bid1,172.00
Offer1,189.00
Previous close1,202.00
Average volume218.83k
Shares outstanding228.95m
Free float191.64m
P/E (TTM)705.40
Market cap2.75bn GBP
EPS (TTM)0.017
GBP
Data delayed at least 20 minutes, as of Jul 04 2022 16:35 BST.
More ▼

Investors Chronicle View

The last IC recommendation on Abcam PLC shares was Hold at 1,465.00 on 13 Sep 2021Read the full article

Board of Directors

1/8

Peter Allen BA (Hons) ACA, Non-Executive Chairman

2/8

Alan Hirzel MS MBA, Chief Executive Officer

3/8

Michael S Baldock BA, Chief Financial Officer

4/8

Giles Kerr BSc ACA, Non-Executive Director and Senior Independent Director

5/8

Mara Aspinall MBA, Non-Executive Director

6/8

Mark Capone MSc, Non-Executive Director

7/8

Bessie Lee MS BA, Non-Executive Director

8/8

Sally Crawford, Non-Executive Director

Contact

Corporate Headquarters:
Abcam plc
Discovery Drive
Cambridge Biomedical Campus
Cambridge
CB2 0AX
UK

T: +44 (0)1223 696 000
F: +44 (0)1223 215 215
E: corporate@abcam.com

For IR related enquires please contact:

James Staveley, VP, Investor Relations
E: james.staveley@abcam.com
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.